NorthWest Biotherapeutics Inc (NWBO)

[Roman516]

The OS data stands as is, "OS DATA GOLDEN"
Ditsch the PFS statistical guess.
DCVax-L works.
DCVax-L added with other compounds provided extended life.
Dr. Linda Liau's early initial indications, 50% survival after 100 months.
NWBO has a path forward and that is a fact worthy for RA approvals, IMPO.
The latest version of the Flaskworks device has been tested and should be used
to increase the probability for higher vaccine production rates, 10x over standard
processes. Advanced automation capability is the objective.